Skip to main content
logo
Medifast, Inc. (MED)
NYSE: MED · Real-Time Price · USD
12.09
-0.53 (-4.20%)
At close: Aug 10, 2026, 4:00 PM EDT
12.19
+0.10 (0.81%)
After-hours: Aug 10, 2026, 4:53 PM EDT

Medifast Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-25.6-18.672.0999.42143.57164.03
Depreciation & Amortization
13.8514.2412.7113.1110.986.81
Stock-Based Compensation
6.87.647.368.1911.059.9
Other Adjustments
2.8813.4612.066.677.321.45
Changes in Inventories
9.0222.1912.1764.2761.19-126.65
Changes in Accounts Payable
-9.05-23.91-34.99-35.71-37.5954.38
Changes in Income Taxes Payable
-0.75-6.610.21-9.161.37-0.95
Changes in Other Operating Activities
0.18-1.482.870.87-3.32-14.43
Operating Cash Flow
8.796.8624.48147.66194.5794.55
Operating Cash Flow Growth
111.70%-71.96%-83.42%-24.11%105.80%-34.88%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-4.78-5.61-7.45-6.48-16.68-34.21
Sale of Property, Plant & Equipment
3.64-----
Purchases of Investments
-148.13-84.41-46.6-59.76--
Proceeds from Sale of Investments
111.6782.0927.535.195.275.15
Investing Cash Flow
-37.6-7.93-26.52-61.05-11.41-29.06

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
--0.040.19-0.81
Repurchase of Common Stock
-0.81-0.37-0.84-6.96-127.96-62.09
Net Common Stock Issued (Repurchased)
-0.81-0.37-0.8-6.77-127.96-61.28
Common Dividends Paid
-0.17-0.2-0.72-73.02-71.62-63.86
Financing Cash Flow
-0.98-0.56-1.52-79.79-199.58-125.13

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
000.05-0.07-0.070.11
Net Cash Flow
-29.78-1.63-3.516.75-16.49-59.54

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
4.011.2517.02141.17177.8960.34
Free Cash Flow Growth
--92.66%-87.94%-20.64%194.83%-56.69%
FCF Margin
1.27%0.32%2.83%13.17%11.13%3.95%
Free Cash Flow Per Share
0.360.111.5512.9315.785.11
Levered Free Cash Flow
-17.13-19.85-2.4126.32159.5248.99
Unlevered Free Cash Flow
-27.27-48.24-2.9124.47160.149.07
SEC Filings: 10-K · 10-Q